Breaking News, Financial News

AMRI

Contract revenues were down 27% for AMRI in 3Q09

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI 3Q09

3Q Revenues: $47.7 million (-22%)

3Q Earnings: $0.4 million

YTD Revenues: $153.0 million (-12%)

YTD Earnings: $2.5 million

Comments: Total contract revenues dropped 27% to $39.7 million from 3Q08; Discovery Services was $11.9 million (-27%), Development/Small Scale Manufacturing was $9.7 million (-33%) and Large Scale Manufacturing was $18.2 million (-22%). Contract revenues are down 17% YTD to $121.8 million. Recurring royalties for the quarter were up 39% to $7.9 million.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters